/
GRTX
$0.09-$0.00 (-0.11%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.02 – $0.15
54% from low
Exchange
OTC Link
CS
Borrow rate
6.39%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-10.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $127.0K | $0 | $0 | $0 | $0 | $0 | $3.8M | $0 |
| Gross profit | −$127.0K | −$267.0K | −$368.0K | −$778.0K | −$114.0K | −$259.0K | −$3.8M | $0 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $18.7M | $42.3M | $54.8M | $52.4M | $31.0M | $24.1M | $3.2M | $349.0K |
| Operating income | −$24.3M | −$50.7M | −$70.6M | −$73.4M | −$51.2M | −$47.0M | −$20.2M | −$6.0M |
| EBITDA | −$23.5M | −$48.6M | −$69.0M | −$72.6M | −$50.6M | −$70.2M | −$20.2M | −$6.0M |
| Net income | −$23.7M | −$51.9M | −$74.2M | −$80.5M | −$62.2M | −$59.1M | −$19.0M | $149.0M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -1.22 | -2.09 | -2.98 | -3.40 | -2.30 | -1.33 | -0.35 | 1.51 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.06
Price
$0.09
Implied downside
-29%
Peer comparison
GALERA THERAPEUTICS INC
GALERA THERAPEUTICS INC
Held by traders on TradeandTell
No one on the platform currently holds GRTX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in GRTX as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded GRTX yet.
